Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study.
By N. Pijls, Pepijn van Schaardenburgh, G. Manoharan, E. Boersma, J. Bech, M. Van't Veer, F. Bär, J. Hoorntje, J. Koolen, W. Wijns and 1 more. Journal of the American College of Cardiology, 2007
1,584 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging, Surgery
View Paper: https://www.semanticscholar.org/paper/f1eb91ac11c6f92a3c8dac7ef0918541065d537f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Surgery
Citations in the corpus
- Computational fluid dynamics applied to cardiac computed tomography for noninvasive quantification of fractional flow reserve: scientific basis. (2013, methodology): “FFR uses a pressure wire to determine the ratio of maximal coronary blood flow through a stenotic artery to the blood flow in the hypothetical case that the artery was normal, and it is the only diagnostic method to date for ischemia detection to demonstrably advance eventfree survival (7,8).”
- Guidelines on myocardial revascularization. (2010, background): “The concept that avoiding unnecessary stenting actually improves outcome was demonstrated in the DEFER [15] and FAME [28] trials.”
- Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes. (2014, background): “*Other reasons for exclusion were no (2 articles) or too short (1) follow-up, unclear or mixture of treatment methods when describing outcomes (3), myocardial bridging (1), simulation-derived fractional flow reserve (FFR) (1), trial design (1), and meta-analysis (1).”
- 2018 ESC/EACTS Guidelines on myocardial revascularization. (2019, neutral): “The DEFER trial enrolled 325 patients scheduled for PCI of an intermediate stenosis.(15) If FFR was >_0.”